No profile data available.
Agfa-Gevaert NV (AGFB.BR) is a healthcare company in the medical sector application systems industry, based in Mortsel, Belgium, with about 4,211 full-time employees.
It reported revenue of 1.09 billion EUR for fiscal year 2025, down 4.6% from fiscal year 2024, and net income of -71.00 million EUR. In Q1 2026 (the quarter ended March 31, 2026) revenue was 236.00 million EUR, down 2.5% from a year before. Its largest business segment, Digital Print and Chemicals, brought in 43% of segment revenue in fiscal year 2025; Other Countries was the largest region with 29%. Its market capitalization was 64.41 million EUR as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Agfa-Gevaert NV develops, manufactures, and markets various analog and digital systems in Belgium and internationally. The company provides healthcare's enterprise imaging platform.
Agfa-Gevaert NV reported 1.09 billion EUR in revenue for fiscal year 2025, down 4.6% from 1.14 billion EUR in fiscal year 2024. In Q1 2026 revenue was 236.00 million EUR.
Digital Print and Chemicals, with 467.00 million EUR or 43% of segment revenue in fiscal year 2025. Next: Radiology Solutions (29%) and Healthcare IT (21%).
Other Countries: 29% of revenue by region in fiscal year 2025, followed by US (20%).
64.41 million EUR as of October 9, 2026.